Vegard Torp Lien (V T Lien)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 4

Top Topics

Metastatic Renal Cell Carcinoma

Molecular Docking

Tyrosine Kinase

Positron Emission Tomography

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Archiv der Pharmazie

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Vegard Torp Lien, Emily Hauge, Syed Nuruddin, Jo Klaveness, Dag Erlend Olberg
Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer. Journal of labelled compounds & radiopharmaceuticals (2023)
Vegard Torp Lien, Solveig Pettersen, Mads Haugland Haugen, Dag Erlend Olberg, Gunhild M Maelandsmo, Jo Klaveness
Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitors. Archiv der Pharmazie 352 (9) (2019)
Vegard Torp Lien, Margrethe Konstanse Kristiansen, Solveig Pettersen, Mads Haugland Haugen, Dag Erlend Olberg, Jo Waaler, Jo Klaveness
Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation. RSC advances 9 (63) (2019)
Vegard Torp Lien, Jo Klaveness, Dag Erlend Olberg
One-step synthesis of [18 F]cabozantinib for use in positron emission tomography imaging of c-Met. Journal of labelled compounds & radiopharmaceuticals 61 (1) (2017)
Vegard Torp Lien, P J Riss
Radiosynthesis of [18)F]trifluoroalkyl groups: scope and limitations. BioMed research international 2014 (2014)